Stocks

The table gives an overview of all stocks, alphabetically sorted.
 AALLON GROUP OYJ AALLON Apr 19, 2021 11.80 +1.29   
 Admicom Oyj ADMCM Apr 19, 2021 97.00 +0.31   
 Afarak Group AFAGR Apr 19, 2021 0.22 0.00   
 Ahlstrom-Munksj÷ AM1 Apr 19, 2021 17.76 +0.11   
 Ahola Transport AHOLA Apr 19, 2021 1.76 +1.15   
 Aktia Bank AKTIA Apr 19, 2021 10.36 0.00   
 Alma Media ALMA Apr 19, 2021 10.40 +3.38   
 Altia ALTIA Apr 19, 2021 10.82 +3.05   
 Apetit APETIT Apr 19, 2021 13.65 +3.41   
 Aspo ASPO Apr 19, 2021 8.92 +0.22   
 Aspocomp Group ACG1V Apr 19, 2021 4.28 +1.90   
 Atria A ATRAV Apr 19, 2021 12.70 +1.60   
 Basware BAS1V Apr 19, 2021 39.05 +0.13   
 BBS-Bioactive Bone Substitutes BONEH Apr 19, 2021 3.47 -1.70   
 Bilot Plc BILOT Apr 19, 2021 7.80 -8.24   
 Biohit B BIOBV Apr 19, 2021 2.17 +0.46   
 Bittium BITTI Apr 19, 2021 6.78 -1.45   
 Boreo Oyj BOREO Apr 19, 2021 48.60 -1.42   
 CapMan CAPMAN Apr 19, 2021 2.56 -0.39   
 Cargotec CGCBV Apr 19, 2021 48.46 +2.24   
 Caverion CAV1V Apr 19, 2021 5.58 0.00   
 Citycon CTY1S Apr 19, 2021 7.30 0.00   
 Componenta CTH1V Apr 19, 2021 4.09 +2.00   
 Consti Plc CONSTI Apr 19, 2021 13.25 -2.57   
 Detection Technology DETEC Apr 19, 2021 27.40 -0.36   
 Digia DIGIA Apr 19, 2021 8.00 -0.25   
 Digitalist Group DIGIGR Apr 19, 2021 0.05 -1.21   
 Dovre Group DOV1V Apr 19, 2021 0.43 +3.40   
 EAB Group EAB Apr 19, 2021 3.75 +1.35   
 Eezy Oyj EEZY Apr 19, 2021 5.76 +2.86   
 


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Titlex

OK